{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:33:45Z","timestamp":1740105225551,"version":"3.37.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017551","name":"Children's National Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaapos.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaapos.2024.104038","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T22:33:18Z","timestamp":1731623598000},"page":"104038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Term infant brain MRI after ROP treatment by anti-VEGF injection versus laser therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Monica","family":"Manrique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeepta","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Murnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Sohel","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christabel","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Vieta-Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-2085","authenticated-orcid":false,"given":"Catherine","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Limperopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6179","authenticated-orcid":false,"given":"Marijean","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2024.104038_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.survophthal.2022.11.007","article-title":"Retinopathy of prematurity: a review of pathophysiology and signaling pathways","volume":"68","author":"Fevereiro-Martins","year":"2023","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.jaapos.2024.104038_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaapos.2024.104038_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0161-6420(93)31665-9","article-title":"Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"100","author":"Schaffer","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archophthalmol.2012.243","article-title":"Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity","volume":"130","author":"Wu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/bjo.86.6.696","article-title":"Retinopathy of prematurity: recent advances in our understanding","volume":"86","author":"Wheatley","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaapos.2024.104038_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaophthalmol.2019.4517","article-title":"Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria [published correction appears in JAMA Ophthalmol 2020;138:105]","volume":"138","author":"Binenbaum","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0161-6420(93)31664-7","article-title":"Diode laser photocoagulation for threshold retinopathy of prematurity: a randomized study","volume":"100","author":"Hunter","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41433-018-0021-7","article-title":"Clinical pharmacology of intravitreal anti-VEGF drugs","volume":"32","author":"Fogli","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jaapos.2024.104038_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajo.2020.05.025","article-title":"Retinopathy of prematurity: evolving treatment with anti-vascular endothelial growth factor [published correction appears in Am J Ophthalmol 2021;231:213]","volume":"218","author":"Hartnett","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib12","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/0008-5472.CAN-17-2254","article-title":"Age-dependent cellular and behavioral deficits induced by molecularly targeted drugs are reversible","volume":"78","author":"Scafidi","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaapos.2024.104038_bib13","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2024.104038_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1814","article-title":"Hypertension and neuroimaging changes after bevacizumab for retinopathy of prematurity","volume":"145","author":"Twitty","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2024.104038_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.survophthal.2021.02.012","article-title":"Neurodevelopmental outcomes in preterm infants with retinopathy of prematurity","volume":"66","author":"Tan","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223972","article-title":"Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaapos.2024.104038_bib17","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3174\/ajnr.A3521","article-title":"New MR imaging assessment tool to define brain abnormalities in very preterm infants at term","volume":"34","author":"Kidokoro","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jaapos.2024.104038_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaapos.2024.104038_bib19","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1542\/neo.14-10-e490","article-title":"Predictive value of neonatal magnetic resonance imaging in preterm infants","volume":"14","author":"Ortinau","year":"2013","journal-title":"Neoreviews"},{"key":"10.1016\/j.jaapos.2024.104038_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12916-023-03141-w","article-title":"Experience of early-life pain in premature infants is associated with atypical cerebellar development and later neurodevelopmental deficits","volume":"21","author":"Cook","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.jaapos.2024.104038_bib21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2024.104038_bib22","first-page":"264.e1","article-title":"Aggressive posterior retinopathy of prematurity in two cohorts of patients in South India: implications for primary, secondary, and tertiary prevention","volume":"23","author":"Shah","year":"2019","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2024.104038_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14767058.2021.1888913","article-title":"Bevacizumab and neurodevelopmental outcomes of preterm infants with retinopathy of prematurity: should we still worry?","volume":"35","author":"Celik","year":"2022","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jaapos.2024.104038_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/archdischild-2019-317720","article-title":"Prophylactic hydrocortisone in extremely preterm infants and brain MRI abnormality","volume":"105","author":"Alison","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jaapos.2024.104038_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpeds.2019.06.030","article-title":"Altered functional brain network integration, segregation, and modularity in infants born very preterm at term-equivalent age","volume":"213","author":"Bouyssi-Kobar","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaapos.2024.104038_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2018.101646","article-title":"Early extra-uterine exposure alters regional cerebellar growth in infants born preterm","volume":"21","author":"Brossard-Racine","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jaapos.2024.104038_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamapediatrics.2017.5323","article-title":"Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression","volume":"172","author":"Twilhaar","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaapos.2024.104038_bib28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.104038_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.104038_bib30","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2016-0057","article-title":"Concerns for development after bevacizumab treatment of ROP","volume":"137","author":"Quinn","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2024.104038_bib33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection [published correction in Arch Ophthalmol 2013;131:212]","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2024.104038_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis","volume":"128","author":"Tsai","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib37","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41372-019-0420-z","article-title":"Neurodevelopmental outcomes in infants treated with intravitreal bevacizumab versus laser","volume":"39","author":"Raghuram","year":"2019","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.jaapos.2024.104038_bib38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","article-title":"Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study","volume":"126","author":"Fan","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib39","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2147\/OPTH.S378520","article-title":"Postnatal growth trajectories and neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity","volume":"16","author":"Zhang","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib40","unstructured":"Gerriets V, Kasi A. Bevacizumab. [Updated 2023 August 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482126\/."},{"key":"10.1016\/j.jaapos.2024.104038_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamaophthalmol.2017.4172","article-title":"Persistent angiographic abnormalities after intravitreal anti-vascular endothelial growth factor therapy for retinopathy of prematurity","volume":"136","author":"Shah","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.104038_bib42","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A\u00a0dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib43","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaapos.2024.104038_bib44","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ophtha.2022.06.042","article-title":"A\u00a0network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity","volume":"129","author":"Chang","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.104038_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nicl.2014.05.013","article-title":"Neonatal physiological correlates of near-term brain development on MRI and DTI in very-low-birth-weight preterm infants","volume":"5","author":"Rose","year":"2014","journal-title":"Neuroimage Clin"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853124003458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853124003458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T16:52:07Z","timestamp":1733935927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853124003458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1091853124003458"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2024.104038","relation":{},"ISSN":["1091-8531"],"issn-type":[{"type":"print","value":"1091-8531"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Term infant brain MRI after ROP treatment by anti-VEGF injection versus laser therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2024.104038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}],"article-number":"104038"}}